|
| |
PatheonPatheon, based in Toronto, Canada, is a leading international provider of pharmaceutical contract manufacturing and development services. Established in 1974, Patheon has grown into a fully integrated service provider to the pharmaceutical and biotechnology sectors.
| Contact Details: |
| 2100 Syntex Court |
| Mississauga |
| Ontario |
| L5N 7K9 |
| Canada |
| Tel: | 905-821-4001 |
| Fax: | 905-812-6791 |
| Email: | patheon@patheon.com |
| WWW: | www.patheon.com/
|
|
Loading...
|
Recent Publications by Patheon: |  |
Engineering of pharmaceutical materials: an industrial perspective.
Crystal engineering provides a rational approach to solving formulation,... | 5th November, 2008
| Pharmaceutical Development Services, Patheon, Inc., 2100 Syntex Court,
| J Pharm Sci. 2008 Aug;97(8):2855-77.
DOI Direct Link |
Method validation and determination of enantiomers and conformers in tofisopam drug substances and drug products by chiral high-performance liquid chromatography and kinetic and thermodynamic study of the interconversion of the conformers.
1-(3,4-Dimethoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiazepi... | 9th December, 2006
| Patheon Inc., Mississauga,
| J Chromatogr A. 2006 Sep 29;1129(1):47-53. Epub 2006 Jul 17.
DOI Direct Link |
Press Releases on Patheon:
|
 |
| Patheon, Inc. announces the appointment of Francisco R. Negron as Vice President and general manager of its Puerto Rico operations |
18th November, 2009 |
Patheon Inc. |
TORONTO, Nov. 18 /PRNewswire-FirstCall/ - Patheon, Inc. (TSX: PTI), a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that
|
| QRxPharma Inks Deal with Patheon for the Manufacture of MoxDuo(TM)CR |
12th October, 2009 |
QRxPharma Limited |
SYDNEY and BEDMINSTER, N.J., Oct. 12 /PRNewswire-FirstCall/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today a contractual agreement with Patheon to manufacture clinical supplies of
|
| Patheon Inc. Expands Manufacturing Facility in Ferentino, Italy |
24th September, 2009 |
Patheon Inc. |
Expansion Increases Capacity for Pharmaceutical Development Services and
Commercial Manufacturing
Source: Patheon Inc.
Website: www.patheon.com
RESEARCH TRIANGLE PARK, NC, Sept. 24
|
| Patheon Announces Date of Third Quarter 2009 Financial Results Release, Conference Call and Webcast |
13th August, 2009 |
Patheon Inc. |
Website: www.patheon.com
TORONTO, Aug. 13 /PRNewswire-FirstCall/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services to the global pharmaceutical industry
|
| JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares |
2nd June, 2009 |
JLL Partners |
NEW YORK, June 2 /PRNewswire/ -- JLL Partners, Inc. and its affiliate, JLL Patheon Holdings, LLC (collectively, "JLL"), announced today that as at 6:00 p.m. (Toronto time) on June 1, 2009
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 656 times since April 2007, the link to the organisation's website has been followed 74 times Recent Search Terms used to find this page: patheon syntex | patheon syntex | patheon pharmaceutical 2009 | Clive Bennett | patheon pharmaceutical, syntex drive mississauga | PATHEON INC. 2100 Syntex Court 1 905 821 4001 | halo pharma | . Search for more companies in Mississauga Search for more companies in Ontario This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Patheon |
